Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.
Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.
复制标题
GPBAR信号偏向通过YAP活性调节NSCLC细胞生长的结构基础和分子机制
DOI:
10.1073/pnas.2117054119
复制
发表时间:
2022-07-19
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
The G protein–coupled bile acid receptor (GPBAR) is the native bile acid receptor and therapeutic target for treating metabolic diseases. However, specific bile acids are suspected to promote cancer progression. We showed that different Gs/arrestin-biased signaling of GPBAR played key roles in non–small cell lung cancer (NSCLC) cell viability. Specifically, β-arrestin–biased GPBAR agonist R399 stimulated cell growth through promoting YAP (Yes-associate Protein) activation. Conversely, GPBAR activation triggered by deoxycholic acid and INT-777, which showed a preference to Gs signaling, inhibited cancer cell progression. Moreover, we delineated key structural determinants of β-arrestin bias and protumor activity of GPBAR and identified that phosphorylation of GPBAR by GRK2/GRK5 contributed to β-arrestin–biased signaling. These results may facilitate rational design of GPBAR-targeting drugs with anticancer benefits. The G protein–coupled bile acid receptor (GPBAR) is the membrane receptor for bile acids and a driving force of the liver–bile acid–microbiota–organ axis to regulate metabolism and other pathophysiological processes. Although GPBAR is an important therapeutic target for a spectrum of metabolic and neurodegenerative diseases, its activation has also been found to be linked to carcinogenesis, leading to potential side effects. Here, via functional screening, we found that two specific GPBAR agonists, R399 and INT-777, demonstrated strikingly different regulatory effects on the growth and apoptosis of non–small cell lung cancer (NSCLC) cells both in vitro and in vivo. Further mechanistic investigation showed that R399-induced GPBAR activation displayed an obvious bias for β-arrestin 1 signaling, thus promoting YAP signaling activation to stimulate cell proliferation. Conversely, INT-777 preferentially activated GPBAR-Gs signaling, thus inactivating YAP to inhibit cell proliferation and induce apoptosis. Phosphorylation of GPBAR by GRK2 at S310/S321/S323/S324 sites contributed to R399-induced GPBAR–β-arrestin 1 association. The cryoelectron microscopy (cryo-EM) structure of the R399-bound GPBAR-Gs complex enabled us to identify key interaction residues and pivotal conformational changes in GPBAR responsible for the arrestin signaling bias and cancer cell proliferation. In summary, we demonstrate that different agonists can regulate distinct functions of cell growth and apoptosis through biased GPBAR signaling and control of YAP activity in a NSCLC cell model. The delineated mechanism and structural basis may facilitate the rational design of GPBAR-targeting drugs with both metabolic and anticancer benefits.
登录
查看更多内容
影响因子:
10.5
作者:
Meng Z;Moroishi T;Guan KL
通讯作者:
Guan KL
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
9.7
作者:
Liu, Xueqing;Chen, Bi;Jiang, Handong
通讯作者:
Jiang, Handong
DOI:
10.1161/hypertensionaha.113.02043
发表时间:
2014-02
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Bathgate-Siryk A;Dabul S;Pandya K;Walklett K;Rengo G;Cannavo A;De Lucia C;Liccardo D;Gao E;Leosco D;Koch WJ;Lymperopoulos A
通讯作者:
Lymperopoulos A
DOI:
10.1107/s0907444909052925
发表时间:
2010-02
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
Adams PD;Afonine PV;Bunkóczi G;Chen VB;Davis IW;Echols N;Headd JJ;Hung LW;Kapral GJ;Grosse-Kunstleve RW;McCoy AJ;Moriarty NW;Oeffner R;Read RJ;Richardson DC;Richardson JS;Terwilliger TC;Zwart PH
通讯作者:
Zwart PH